Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mobia MedicalMOBI +6.98%10 14-Day RSI is 48.47 as of Aug. 29, 2026. GuruFocus rates MOBI with a GF Score™ of 10/100. The stock has 1 warning sign investors should review. Among 865 Medical Devices & Instruments companies, Mobia Medical ranks better than 77.34% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-08-29), Mobia Medical's 14-Day RSI is 48.47.
The industry rank for Mobia Medical's 14-Day RSI or its related term are showing as below:
MOBI's 14-Day RSI is ranked better than 77.34% of 865
companies
in the Medical Devices & Instruments industry
Industry Median: 49.6
vs MOBI: 48.47
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Mobia Medical 14-Day RSI Related Terms
MOBI vs CATX, CV, LAB: 14-Day RSI Comparison
For the Medical Devices subindustry, Mobia Medical's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mobia Medical 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mobia Medical's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Mobia Medical's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mobia Medical (MOBI) has a 14-Day RSI of 48.47 as of Aug. 29, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Mobia Medical and its competitors. According to the industry distribution chart, Mobia Medical ranks #196 out of 865 companies in the Medical Devices & Instruments industry, placing it in the top 22.7%.
Is Mobia Medical's 14-Day RSI too high?
Mobia Medical's current 14-Day RSI is 48.47. The Medical Devices & Instruments industry median 14-Day RSI is 49.60. Mobia Medical's value of 48.47 is 2.3% below this industry median. Based on the distribution chart, Mobia Medical ranks #196 out of 865 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Mobia Medical has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Mobia Medical's 14-Day RSI compare to CATX and CV?
According to the Medical Devices & Instruments industry distribution chart, Mobia Medical ranks #196 out of 865 companies for 14-Day RSI. This places Mobia Medical in the top 23% of its industry — outperforming the majority of peers. The industry median 14-Day RSI is 49.60. Mobia Medical's value of 48.47 is 2.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 49.60, based on 865 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mobia Medical's current 14-Day RSI of 48.47 is 2.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Mobia Medical and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 49.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mobia Medical's current 14-Day RSI is 48.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mobia Medical stock overvalued right now?
Mobia Medical (MOBI) has a current 14-Day RSI of 48.47. The current 14-Day RSI is 48.47 and 2.3% below the Medical Devices & Instruments industry median of 49.60. Mobia Medical's overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Mobia Medical (MOBI), the current 14-Day RSI is 48.47 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.
10GF Score
Get the complete analysis for MOBI
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MOBI has been successfully added to your 
